Centre for Infectious Disease Research in Zambia
Quick facts
Marketed products
Phase 3 pipeline
- ROTAVAC® · Infectious Diseases
ROTAVAC is a live attenuated oral vaccine that protects against rotavirus infection. - ROTAVAC 5D · Infectious Diseases
ROTAVAC 5D is a vaccine that protects against rotavirus infection.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Centre for Infectious Disease Research in Zambia portfolio CI brief
- Centre for Infectious Disease Research in Zambia pipeline updates RSS
Frequently asked questions about Centre for Infectious Disease Research in Zambia
What are Centre for Infectious Disease Research in Zambia's marketed drugs?
Top marketed products include PrEP.
What is Centre for Infectious Disease Research in Zambia's pipeline?
Centre for Infectious Disease Research in Zambia has 2 drugs in Phase 3, 0 in Phase 2, 2 in Phase 1. Late-stage candidates include ROTAVAC®, ROTAVAC 5D.
Related
- PrEP
- Sector hub: All tracked pharma companies